https://onlinelibrary.wiley.com/doi/10.1002/acn3.51325
Interpretation
NAC was well‐tolerated in progressive MS, although reduction in fatigue on NAC was similar to placebo. Antioxidant blood and MRS biomarkers were not significantly altered by NAC, which could be due to dose, route of administration, time of sample collection, short half‐life, or lack of effect.
https://multiplesclerosisnewstoday....ms-fatigue-randomized-trial-nacetyl-cysteine/
Interpretation
NAC was well‐tolerated in progressive MS, although reduction in fatigue on NAC was similar to placebo. Antioxidant blood and MRS biomarkers were not significantly altered by NAC, which could be due to dose, route of administration, time of sample collection, short half‐life, or lack of effect.
https://multiplesclerosisnewstoday....ms-fatigue-randomized-trial-nacetyl-cysteine/